EVFM News and Press, Evofem Biosciences Inc. From 04/18/24

Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO PR Newswire -- Application allowed with broad method claims that are Orange Book-listable -- -- Once issued, this will be Evofem's fifth patent covering Hormone-Free "In th...

2024-03-27 13:52:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evofem Biosciences (NASDAQ: EVFM ) just reported results for the fourth quarter of 2023. Evofem Biosciences reported earnings per share of -44 cents. The company repor...

Aditxt (NASDAQ: ADTX) previously entered into a definitive agreement to acquire Evofem Biosciences Inc. (OTCQB: EVFM) , which is believed to represent a compelling opportunity to accelerate Evofem’s growth trajectory, as a subsidiary of Aditxt, into a multi-product women’s health ...

Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 PR Newswire -- Third Consecutive Year of Phexxi Net Sales Growth -- -- Total Operating Expense Reduced 64% from 2022 Levels -- -- Sales and marketing expense as a percent...

Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal PR Newswire — Medi-Cal serves more than 15.4 million Californians — — 7.4% improvement in Phexxi rebate to take effect July 1, 2...

For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy PR Newswire -- New weight loss drugs like Ozempic, Wegovy and Zepbound may make oral birth co...

2024-02-01 08:48:44 ET More on Evofem Biosciences Aditxt to acquire women’s health company Evofem Biosciences Seeking Alpha’s Quant Rating on Evofem Biosciences Historical earnings data for Evofem Biosciences Financial information for Evofem Bio...

Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023 PR Newswire Evofem Delivers Third Consecutive Year of Phexxi Net Sales Growth Total Operating Expense Reduced More Than 60% from 2022 Levels SAN DIEGO ...

Washington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game PR Newswire — Removal of Prior Authorization Upgrades Phexxi Coverage for Nearly 1.8 Million Washingto...

2023-12-12 08:59:04 ET More on Evofem Biosciences Evofem Biosciences expects to see third consecutive quarter of growth Evofem says no Phexxi generic until 2033 after company amends ANDA Financial information for Evofem Biosciences For further details see: ...